2717 related articles for article (PubMed ID: 18926712)
1. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
3. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
5. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
6. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
[TBL] [Abstract][Full Text] [Related]
7. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of adjuvant radiotherapy on preventing lymph node metastasis after Ivor-lewis esophagectomy in esophageal cancer.
Chen H; Wang Z; Yang Z; Shang B; Liu X; Chen G
Ann Surg Oncol; 2013 Aug; 20(8):2721-6. PubMed ID: 23463093
[TBL] [Abstract][Full Text] [Related]
9. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
10. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.
Chen G; Wang Z; Liu XY; Liu FY
World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905
[TBL] [Abstract][Full Text] [Related]
11. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
12. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
14. [Surgical treatment and prognosis in patients with squamous cell carcinoma of thoracic esophagus].
Zhang DK; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Ma GW; Zhu ZH; Dai Y; Rong TH
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1333-6. PubMed ID: 19094566
[TBL] [Abstract][Full Text] [Related]
15. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer.
Kang CH; Kim YT; Jeon SH; Sung SW; Kim JH
Eur J Cardiothorac Surg; 2007 Feb; 31(2):154-60. PubMed ID: 17145185
[TBL] [Abstract][Full Text] [Related]
16. Curative effect comparison between Ivor-Lewis esophagectomy and left transthoracic esophagectomy in treatment of middle thoracic esophagus carcinoma.
Song L; Liu Y; Wang Z; Ren WG; Liu XY
Hepatogastroenterology; 2012 May; 59(115):738-41. PubMed ID: 22024231
[TBL] [Abstract][Full Text] [Related]
17. [Recurrence pattern and prognosis of esophageal cancer following tumor resection].
Chen J; Sang M; Chen Y
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):293-5. PubMed ID: 10920988
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
19. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
